Trinity Biotech

Trinity Biotech Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Trinity Biotech (TRIB) as of Nov 10, 2026 is 255.49. In the previous year, Days Inventory Outstanding (DIO) was 176.29 — a change of 44.93% (higher).

Days Inventory Outstanding

255.49

YoY

44.93%

Last updated:

Days Inventory Outstanding (DIO) of Trinity Biotech is 2025 255.49 . Days Inventory Outstanding (DIO) of Trinity Biotech was 2024 176.29 . It decreases by 44.93% higher compared to the previous year.

The Trinity Biotech Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2018
199.35 USD
Jan 1, 2019
223.41 USD
Jan 1, 2020
206.55 USD
Jan 1, 2021
193.67 USD
Jan 1, 2022
155.76 USD
Jan 1, 2023
194.63 USD
Jan 1, 2024
176.29 USD
Jan 1, 2025
255.49 USD
The Trinity Biotech Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
255.49+44.93%
176.29-9.42%
194.63+24.95%
155.76-19.57%
193.67-6.24%
206.55-7.55%
223.41+12.07%
199.35-4.68%
209.15-0.63%
210.46-11.44%
237.64+5.91%
224.37—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Trinity Biotech Stock analysis

What does Trinity Biotech do? Trinity Biotech Plc develops, manufactures, and markets medical diagnostic products for clinical laboratories and point-of-care segments. The company operates through the Americas and Rest of World segments, offering products classified as POC, emergency medicine, clinical laboratory, and blood bank screening. Its POC brands include Uni-Gold and Recombigen, used for detecting autoimmune, infectious, and sexually transmitted diseases, diabetes, and liver and intestinal disorders. Emergency medicine diagnostics target acute care testing, STAT labs, pre/post-operative units, physician office labs, and central laboratories. The company supplies clinical laboratory market with reagent products and other products through its clinical chemistry business, while its blood bank screening business unit manufactures products to screen donated blood for transfusion-transmissible infections. Trinity Biotech's products serve healthcare providers in clinical and point-of-care settings, with the Americas and Rest of World segments representing key geographic markets for its diagnostic solutions. Trinity Biotech generates revenue from the sale of diagnostic products across multiple segments, including POC testing, emergency medicine diagnostics, clinical chemistry reagents, and blood bank screening. The company's brands, Uni-Gold and Recombigen, are central to its point-of-care offerings, while its clinical chemistry and blood bank screening businesses provide complementary revenue streams in laboratory and blood donation settings. Trinity Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Trinity Biotech stock

Days Inventory Outstanding (DIO) of Trinity Biotech is 255.49 in 2025.

Days Inventory Outstanding (DIO) of Trinity Biotech changed from 176.29 to 255.49, representing a 44.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Trinity Biotech since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Trinity Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Trinity Biotech

All Key Metrics — Trinity Biotech